S1 filings / 16
#16
| id | 16 |
|---|---|
| company_id | 8457 |
| ticker | SCTX |
| filing_date | 2026-07-10 |
| filing_url | https://www.sec.gov/Archives/edgar/data/0001853921/000119312526300994/ |
| business_description | Scribe Therapeutics is a clinical-stage biotechnology company developing engineered in vivo CRISPR-based genetic medicines designed to tr... |
| total_revenue | $51.2M (FY2025) |
| operating_loss | -$26.1M (FY2025) |
| cash_burn | — |
| total_assets | $65.2M (as of March 31, 2026) |
| created_at | 2026-07-11T21:13:50.134314+00:00 |
| updated_at | 2026-07-22T09:14:57.973743+00:00 |
| total_revenue_usd | 51174000 |
| operating_loss_usd | -26070000 |
| cash_burn_usd | — |
| total_assets_usd | 65208000 |
| source_record_id | 1223 |
| tenant_id | 1 |